EGEmre Günakan

Emre Günakan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emre Günakan has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serum osteopontin as a diagnostic marker for missed abortion: evidence from a prospective study

    by Denizhan Bayramoğlu, Erhan Okuyan, Yusuf Başkıran, Emre Günakan, Zeynep Bayramoğlu, Celal Akdemir

    Serum osteopontin as a diagnostic marker for missed abortion: evidence from a prospective study - Journal of the Turkish-German Gynecological Association

  • Open Access

    Standardization of Marking of the Surgical Borders According to the Fibonacci (Golden) Ratio in Female Genital Aesthetic Surgery: Presentation of a Novel Marking Gadget

    by Erhan Okuyan, Emre Gunakan, Nurullah Peker

    The anatomy of the female external genitalia may differ due to developmental or acquired events. However, several anatomical landmarks such as the anterior and posterior commissures, glans clitoridis, and perineal body do not differ across most patients and can be used to evaluate post-surgical tissue symmetry and proportion. Patient preference seems to be subjective; interestingly, however, the desired post-surgical appearance is very similar in itself, almost to the standard in most patients. In addition, surgeons may change the entire process according to their individual aesthetic perceptions and experience. Thus, the outcomes of genital aesthetic surgery may be affected by multiple factors, with patient preference and surgical evaluation and approach appearing to be the most person-dependent. From this perspective, we defined a sticker model for marking the external female genitalia in genital aesthetic surgery. Inspired by the golden ratio, we incorporated the Fibonacci spiral in the stickers.

  • Open Access

    The relationship between maternal thyroid volume, TSH levels, and Healthy Eating Index scores in BMI-matched pregnant women with hyperemesis gravidarum

    by Erhan Okuyan, Ozlem Karabay Akgul, Lena Tureyici, Halit Atac, Mesut Cetin, Emre Günakan, Fethi Karakaya

    The aim is to investigate the relationship between thyroid volume measurement and healthy nutrition questionnaire scoring in pregnant women diagnosed with hyperemesis gravidarum (HEG). One hundred and fifty pregnant women with a BMI of 15-25 kg/m2 and between the ages of 17 and 42 who were diagnosed with HEG at 11-14 weeks of gestation were included in the study. Patients with a history of any disease, drug use, and previously diagnosed eating disorders were excluded. All patients were subjected to the Healthy Eating Index (HEI) questionnaire. The cutoff value for HEI score was determined as 80 points. Patients were evaluated in two groups: group 1 (HEI p = .02) and lower HEI scores (p < .001). On the other hand, it was not significantly associated with ketonuria (p = .47), and parity status (p = .82). In our study, we found that there may be an increase in thyroid volume in pregnant women with HEG with lower TSH levels and eating scores. Thyroid volume may predict the patients with probable eating disorders and further studies on thyroid volume in patients with HEG may contribute to the literature.


  • Open Access

    Vitamin D deficiency and pregnancy outcome: Does it have a role in preeclampsia etiology?

    by Mehmet Tunc, Emre Günakan, Ceren Katar Yildirim, Nurten Çi̇lek, Canan Tapkan, Onur Dalay

    Purpose: Vitamin D deficiency is higher in pregnancy and there is evidence on its relationship with various obstetric disorders. The aim of this study was to investigate the association between preeclampsia and vitamin D levels in pregnant women. Methods: This study included 1209 women. General characteristics, laboratory results and obstetric outcomes were evaluated. As globally accepted vitamin D deficiency was defined as <20 ng/mL and we determined a critical level of for deficiency that is 8.335 ng/mL in ROC analyses. Results: The median age of the patients was 28 (17-45). The percentage of need of labor induction was 11.9%. Cesarean section rate was 32.5%. The incidence of VDD was 81% (n:979). Gestational week (38.6 vs. 38.5), birth weight (3291gr vs. 3248gr) and head circumference (34.98cm vs. 34.9cm) were not different groups with regard to VDD (p: 0.145, p:0.184 and p:0.358, respectively). Besides; VDD was significantly associated with risk of labor induction and PROM in univariant analyses. 38 patients were diagnosed with preeclampsia. The diagnostic accuracy rate of level vitamin D level as 8.335 ng/mL was 76.1 %. According to multivariate analysis 25-OH vit D level of 8.335 ng/mL (HR: 2.94; 95%CI: 2.04-4.22; P < 0.001) and nulliparity (HR: 2.05; 95%CI: 1.43-2.93; P < 0.001) were independent factors significantly associated with preeclampsia. Conclusion: Low levels of vitamin D was associated with preeclampsia in our study. The association was stronger in lower levels. VDD is very frequent and further studies may also support advances in a health problem worldwide. Amaç: Vitamin D eksikliği gebelikte data sık görülmektedir ve çeşitli obstetrik rahatsızlıklarla ilişkisi olduğuna yönelik kanıtlar mevcuttur. Bu çalışmanın amacı gebelerde vitamin D düzeyi ile preeklempsi arasındaki ilişkiyi araştırmaktır. Yöntem: Çalışmaya 1209 kadın dahil edilmiştir. Genel karakteristikler, laboratuar sonuçları ve obstetrik sonuçlar değerlendirilmiştir. Global olarak da kabul edilmiş olan <20ng/mL, vitamin D eksikliği (VDE) olarak tanımlanmıştır. ROC analizinde eksiklik için kritik düzey 8.335 ng/mL olarak tespit edilmiştir. Sonuçlar: Hastaların ortanca yaşı 28 (17-45) idi. Hastaların %11.9'unda doğum indüksiyonu gerekmiştir. Sezaryen seksiyo oranı %32.5 idi. Hastaların %81'inde (n:979) VDE tespit edilmiştir. Gestasyonel hafta (38.6 vs. 38.5), doğum ağırlığı (3291gr vs. 3248gr) ve baş çevresi (34.98cm vs. 34.9cm) VDE olmayan ve olan gruplarda benzerdi (p: 0.145, p:0.184 ve p:0.358, sırasıyla). Bunun yanı sıra, tek değişkenli analizde VDE'li grupta doğum indüksiyonu ve erken membran rupture daha yüksek oranda tespit edilmiştir. Otuz sekiz hasta preeklempsi tanısı almıştır. Vitamin D düzeyinin 8.335 ng/mL olarak tanısal doğruluk oranı %76.1 idi. Çok değişkenli analizde 8.335 ng/mL 25-OH vitamin D düzeyi (HR: 2.94; %95 GA: 2.04-4.22; p:<0.001) ve nulliparite (HR: 2.05; %95 GA: 1.43-2.93; P < 0.001) preeklempsi için istatistiksel olarak anlamlı bağımsız risk faktörleri olarak tespit edilmiştir. Sonuç: Çalışmamızda azalmış vitamin D düzeyi preeklempsi ice ilişkili olarak bulunmuştur. İlişkinin vitamin D düzeyi düştükçe, arttığı gözlenmiştir. VDE oldukça sık izlenmektedir ve ileride yapılacak çalışmalar dünya genelinde izlenen bu sağlık sorununa destekleyici sonuçlar ortaya koyacaktır.


  • Extending the culture of cleavage-stage embryos to the blastocyst stage after warming increases the chance of live birth: does it have a regenerative effect?

    by Göğşen Önalan, Mehmet Tunç, Aytaç Tohma, Emre Günakan, Tahir Eryılmaz, Hulusi B. Zeyneloğlu

    Purpose We aimed to evaluate the effect of extending the culture of cleavage-stage embryos to the blastocyst stage in vitrified–warmed cycles on pregnancy outcomes. Methods This is a retrospectively designed pilot study of a single center. All patients who applied for freeze-all cycle procedures during in vitro fertilization treatment were included in the study. Patients were classified into three subgroups. The embryos obtained were frozen at the cleavage or blastocyst stage. After a warming process, the cleavage-stage embryos were divided into two subgroups: the first group of embryos was transferred (vitrification day 3–embryo transfer (ET) day 3 (D3T3)) on the warming day; for the second group, the embryo culture was extended to the blastocyst stage (vitrification day 3–ET day 5 (after the extension of the embryo culture to the blastocyst stage), (D3T5)). Frozen blastocyst-stage embryos were transferred after warming (vitrification day 5–ET day 5 (D5T5)). Hormone replacement treatment was the only endometrial preparation regimen given during the embryo transfer cycle. The main outcome of the study was live birth rates. The clinical pregnancy rate and positive pregnancy test rate were determined as the secondary outcomes of the study. Results The study included a total of 194 patients. The positive pregnancy test rates (PPR) and clinical pregnancy rates (CPR) of the D3T3, D3T5, and D5T5 groups were 14.0% and 59.2%; 43.8% and 9.3%; and 56.3% and 39.6%, respectively (p < 0.001 and p < 0.001). The live birth rates (LBR) of patients in the D3T3, D3T5, and D5T5 groups were 7.0%, 44.7%, and 27.1%, respectively (p < 0.001). In subgroup analysis of patients with a poor number of 2PN embryos (defined as having < = 4 2PN embryos), the D3T5 group had significantly higher PPR (10.7%, 60.6%, 42.4%; p < 0.001), CPR (7.1%, 57.6%, 39.4%; p < 0.001), and LBR (3.6%, 39.4%, 21.2%; p: 0.001). Conclusion Extending the culture after warming to the blastocyst stage may be a better alternative than a cleavage-stage embryo transfer.


  • Diet and pravastatin administration prior to in vitro fertilization treatment may improve pregnancy outcome in women with dyslipidemia

    by Hulusi Bulent Zeyneloglu, Yusuf Aytac Tohma, Emre Gunakan, Mehmet Ali Abasıyanık, Ceren Sozen, Gogsen Onalan

    In this study, we aimed to identify whether using statins may increase the chance of pregnancy in In Vitro Fertilisation / Intra-Cytoplasmic Sperm Injection (IVF/ICSI) patients with hyperlipidaemia. Therefore, in this retrospective cohort study, 70 patients constituted the study population and all patients were managed by lipid lowering diet. Ten mg pravastatin (pravachol DEVA, Istanbul, Turkey) was added to therapy in case of resistant hypercholesterolaemia after 15 days of the diet. Fifty-one patients were treated with diet only and the remaining nineteen patients were offered both diet and pravastatin. Clinical pregnancy rate was significantly better with the patients who used pravastatin (68.4% vs. 39.2%, p = .029). Ongoing pregnancy rates were 63.2% and 33.3% with pravastatin and diet only, respectively, which were statistically significant (p:.024). According to multivariate analysis, pravastatin use was found independently and statistically significant for clinical pregnancy and ongoing pregnancy rate after IVF/ICSI in patients with dyslipidemia (HR 3.79; 95% CI 1.31–10.97; p:.014 and HR 3.18; 95% CI 1.22–8.27; p:.018). When we analysed stratified data according to the AMH levels, we noticed that as AMH levels increased, the pregnancy rates increased; the most benefit from pravastatin was in the group with AMH levels >2 ng/mL.


  • Open Access

    Psychological conditions of patients whose infertility treatment was postponed due to the novel coronavirus pandemic lockdown

    by Emre Günakan, Aytaç Tohma, Gamze Özçürümez, Göğşen Önalan, Tayfun Cok, Hulusi Zeyneloglu

    Aim: In this study, we planned to examine the psychological status of patients who were required to postpone their infertility treatment, by means of an online survey.Methods: Sixty patients who were in the follow-up were informed and an access link of online survey, which included questions about age, infertility status, Beck’s depression inventory(BDI) and Hamilton’s anxiety rating scale (HAM-A), were sent to them. Three different grouping systems were used based on (i-) age, (ii-) fertility treatment status and (iii-) indications for assisted reproduction technology treatment.Results: Mean scores of BDI and HAM-A in the whole group were 39.2(25-67) and 22.1(11-45), respectively. In the evaluation of survey scores according to indications of fertility treatment, BDI scores were between 34.2-44.7 and there was no statistical significance between the groups (p:0.182). HAM-A scores were between 18.7-38.0 and there was no statistical significance between the groups (p:0.185). In addition, there was no statistical significance between groups for BDI and HAM-A (p: 0.962 and 0.423, respectively) according to patients’ ART treatment status at the time the 2019-nCoV outbreak began in our country.Conclusion: Infertile patients will be more prone to depression and anxiety, and it should be noted that potential treatment postponements may increase their depression and anxiety.

  • Survival impact of number of removed para-aortic lymph nodes in stage I epithelial ovarian cancer

    by Emre Günakan, Hüseyin Akıllı, Atacan Timuçin Kara, Özden Altundağ, Asuman Nihan Haberal, Mehmet Mutlu Meydanlı, Ali Ayhan

    Purpose The survival effect of presence or absence of lymphadenectomy in early-stage epithelial ovarian cancer (EOC) was priorly shown but the effect of number of removed lymph nodes kept in background. We aimed to evaluate the survival impact of number of removed lymph nodes and their localizations in stage I EOC. Methods This study included 182 patients. The best cut-off levels for number of pelvic and para-aortic lymph nodes (PaLN) were 24 and 10, respectively. Univariate and multivariate survival analyses were performed for these cut-offs and other prognostic factors. Results The median age of the patients was 49. The median number of removed pelvic and paraartic lymph nodes were 29 and 9, respectively. The median overall (OS) and progression-free survival (PFS) were 67 and 50 months, respectively. The 5-year OS rate was 89.6%. Recurrence occured in 24 (19.5%) patients. In univariate analyses tumor grade (p: 0.005), pelvic LN number (p: 0.041) and PaLN number (p: 0.004) were the factors that were significantly associated with PFS. Tumor grade and PaLN number were independently and significantly associated with PFS in multivariate analyses (p: 0.015 and p: 0.017, respectively). In OS analyses, age, tumor grade, presence of LVI, number of pelvic and PaLNs were the significantly associated factors (p < 0.05 for all). In multivariate analyses, age and PaLN number were independently and significantly associated with OS (p: 0.011 and p: 0.021, respectively). Conclusions The number and localizations of removed lymph nodes may have a survival affect in stage I EOC. We also think that this study may constitute a kernel point for larger prospective series on lymph node number and lymphatic regions.


  • Evaluation of the uterine cavity and fallopian tubes in one step in patients undergoing assisted reproductive technology treatment: Hysterosalpingofoam sonography (hyfosy) in combination with hysteroscopy

    by Hulusi Zeyneloglu, Yusuf Aytaç Tohma, Göğşen Önalan, Emre Günakan

    Aim: To report on the utilization of hysterosalpingo-foam sonography (HyFoSy) with hysteroscopic evaluation for selected patients undergoing Assisted Reproductive Technology Treatment (ART), whereby we aimed to assess the effectiveness of HyFoSy before hysteroscopy. Material and Method: This retrospective study included 36 infertile women referred to Baskent University’s Ankara Hospital Infertility Clinic in 2017-2019. HyFoSy was applied with hysteroscopy in one step for patients who had not previously been evaluated for tubal patency or who had to be re-evaluated. Results: Two patients were diagnosed with tubal obstruction by HyFoSy and were treated with hysteroscopic tubal catheterization, and tubal patency was obtained after this procedure. HyFoSy was applied in seven patients (19.49%) because their previous hysterosalpingography (HSG) reports were doubtful. Although previous HSG had shown tubal obstruction in three patients, the standard passage of the foam from the fallopian tubes to the abdominal cavity was observed when HyFoSy was applied. Conclusion: The one-step method that we apply in our clinic seems appropriate for both patients and clinicians because it speeds up the evaluation steps of the uterine cavity and fallopian tubes before the next ART attempt.

  • Open Access

    Survival Impact of Number of Removed Para-Aortic Lymph Nodes in Stage I Epithelial Ovarian Cancer

    by Emre Günakan, Hüseyin Akıllı, Atacan Timuçin Kara, Özden Altundağ, Asuman Nihan Haberal, Mehmet Mutlu Meydanlı, Ali Ayhan

    Purpose: The survival effect of presence or absence of lymphadenectomy in early stage epithelial ovarian cancer (EOC) was priorly shown but the effect of number of removed lymph nodes kept in background. We aimed to evaluate the survival impact of number of removed lymph nodes and their localizations in stage I EOC.Methods: Study included 182 patients. Best cut-off levels for number of pelvic and para-aortic lymph nodes(PaLN) were 24 and 10, respectively. Univariate and multivariate survival analyses were performed for these cut-offs and other prognostic factors. Results: Median age of the patients was 49. Median number of removed pelvic and paraartic lymph nodes were 29 and 9, respectively. Median overall(OS) and Progression-free survival(PFS) were 67 and 50 months, respectively. The OS rate was 89.6%. Recurrence occured in 24 (19.5%) patients. In univariate analyses tumor grade(p:0.005), pelvic LN number(p:0.041) and PaLN number(p:0.004) were the factors that were significantly associated with PFS. Tumor grade and PaLN number were independently and significantly associated with PFS in multivariate analyses (p:0.015 and p:0.017, respectively). In OS analyses, age, tumor grade, presence of LVI, number of pelvic and PaLNs were the significantly associated factors (pConclusions: The number and localizations of removed lymph nodes may have a survival affect in stage I EOC. We also think that this study may constitute a kernel point for larger prospective series on lymph node number and lymphatic regions.